0
0
CHICAGO — Groundbreaking research has revealed that glioblastoma, the most aggressive and lethal form of brain cancer, maintains its growth by “hijacking” a specific sugar metabolism pathway to neutralize the body’s immune defenses. The study, published this week in the Proceedings of the National Academy of Sciences (PNAS), identifies how specialized immune cells within the tumor environment consume fructose to create a protective shield for the cancer, offering a promising new target for future immunotherapies.
The Metabolic “Brake” on Immunity
Glioblastoma has long been a challenge for modern medicine, largely due to its ability to evade the body’s natural defense systems. Researchers at Northwestern University’s Feinberg School of Medicine have discovered a key reason for this evasion: the tumor forces surrounding immune cells to change their “diet.”
The study focused on microglia and macrophages—immune cells that should theoretically attack the cancer. Instead, these cells were found to express a specific transporter called GLUT5. This protein allows the cells to take up and metabolize fructose, a simple sugar. When these immune cells process fructose, they undergo a functional shift, entering an “immunosuppressive” state. In this state, rather than fighting the tumor, they release signals that dampen the activity of T-cells—the immune system’s primary “soldiers.”
“Across several mouse models, when we removed the fructose transporter, the tumors simply didn’t grow,” said Dr. Jason Miska, lead investigator and assistant professor of neurological surgery at Northwestern University. “It was far more dramatic than we anticipated.”
Rewiring the Brain’s Resources
The discovery adds a sophisticated layer to our understanding of cancer metabolism. While it is well-known that cancer cells consume high amounts of glucose to fuel rapid division, this research shows that the tumor microenvironment is far more complex.
A supporting study published in Nature in 2025 demonstrated that glioblastoma “rewires” the brain’s cortical glucose metabolism. Instead of using sugar for healthy brain functions like neurotransmitter synthesis, the tumor redirects these resources to build DNA and cellular membranes.
The new PNAS study suggests that while the tumor consumes the glucose, it simultaneously trains the surrounding immune cells to feed on fructose. This dual-track metabolic strategy ensures the tumor has the energy to grow while ensuring the local immune environment remains “quiet” and non-threatening to the cancer cells.
Key Findings at a Glance
| Discovery | Impact on Tumor |
| GLUT5 Expression | Allows immune cells to “eat” fructose instead of glucose. |
| Immune Suppression | Fructose metabolism triggers signals that disable T-cells. |
| Genetic Deletion | Removing GLUT5 in models led to rapid tumor rejection. |
| T-cell Expansion | Without GLUT5, “cancer-killing” CD8+ T-cells multiplied rapidly. |
Why Fructose Matters
Fructose is a common sugar found naturally in fruits, but it is most prevalent in modern diets through high-fructose corn syrup used in processed foods. While the liver typically handles fructose processing, this research proves that under the “instruction” of a tumor, immune cells in the brain can switch to this alternative fuel source.
By using fructose, these microglia act as a metabolic “brake.” In mice where the GLUT5 transporter was genetically removed, the immune cells became more inflammatory—a good thing in the context of cancer—and began to recognize and attack the tumor cells effectively.
Implications for Future Treatment
For years, immunotherapy has revolutionized the treatment of cancers like melanoma and lung cancer, but it has largely failed in glioblastoma. This research may explain why. If the immune cells meant to support the therapy are busy metabolizing fructose and sending “stand down” signals, the treatment cannot work.
“Our work suggests that targeting fructose metabolism in these specialized immune cells could be a strategy to enhance the power of immunotherapy,” Dr. Miska noted.
Researchers are now looking toward developing small-molecule inhibitors or antibodies that can block GLUT5. The goal is to “release the brake” on the immune system, potentially making glioblastoma vulnerable to existing checkpoint inhibitors or cancer vaccines.
A Note of Caution for Patients
While the link between sugar and cancer growth often leads to headlines suggesting that dietary changes can cure disease, experts urge a balanced perspective.
“The key message for patients is that this is a promising potential new drug target, not a dietary panacea,” said Dr. Anil Madhavapeddy, a neuro-oncologist not involved in the study. “We are still years away from knowing whether blocking fructose metabolism inside the brain will be safe and effective in people.”
There is currently no clinical evidence that simply eliminating fruit or sugar from the diet will shrink an existing glioblastoma. The “hijacking” described in the study happens at a cellular level within the unique environment of the brain, and the body requires a baseline of various nutrients to maintain overall strength during cancer treatment. However, maintaining a diet low in ultra-processed foods remains a standard recommendation for general metabolic health and reducing chronic inflammation.
Limitations and the Path Ahead
The study’s most significant results were observed in genetically engineered mouse models. While these models are essential for medical progress, the human brain is significantly more complex. Furthermore, glioblastoma is highly “heterogeneous,” meaning the tumor cells can vary greatly from one patient to another. Some tumors might rely heavily on fructose, while others might use different metabolic pathways entirely.
Future research will focus on whether blocking GLUT5 throughout the body causes side effects in the liver or kidneys, which naturally use fructose transporters. For now, the discovery provides a vital new map of the “metabolic wiring” that makes brain cancer so resilient.
References
- https://health.economictimes.indiatimes.com/news/industry/brain-tumours-take-control-of-sugar-metabolism-to-grow-study-suggests/129653787?utm_source=top_story&utm_medium=homepage
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
